Contact
Please use this form to send email to PR contact of this press release:
Cellceutix Provides Brilacidin Update; New Class of Antibiotics to Enter Phase 3
TO:
Please use this form to send email to PR contact of this press release:
Cellceutix Provides Brilacidin Update; New Class of Antibiotics to Enter Phase 3
TO: